Literature DB >> 9854706

Surgical outcome of transconjunctival cryosurgical extraction of orbital cavernous hemangioma.

M Gdal-On1, Y A Gelfand.   

Abstract

BACKGROUND AND
OBJECTIVE: Transconjunctival cryosurgical extraction (TCE) is not an accepted method for the removal of most intraorbital tumors, and thus is not routinely performed. This study evaluates TCE for orbital cavernous hemangioma (OCH), which, due to its specific vascular structure, is suitable for this technique. PATIENTS AND METHODS: In this retrospective case series, the medical charts of 12 consecutive patients with OCH who underwent TCE were reviewed. The operative complications and the surgical outcome were analyzed.
RESULTS: Eleven tumors were intraconal and 1 was extraconal. No tumor involved the orbital apex. In 10 patients (83%), the operation was uneventful. One patient lost vision due to intraoperative cilioretinal arterial occlusion. In another patient, the tumor could not be identified and was subsequently removed via lateral orbitotomy.
CONCLUSION: TCE, a relatively minor operation, is as safe as more extensive surgical procedures for the removal of OCH not located in the posterior third of the orbital space.

Entities:  

Mesh:

Year:  1998        PMID: 9854706

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers        ISSN: 1082-3069


  3 in total

1.  Endoscopic transnasal intraorbital surgery: our experience with 16 cases.

Authors:  Paolo Castelnuovo; Iacopo Dallan; Davide Locatelli; Paolo Battaglia; Paolo Farneti; Peter Valentin Tomazic; Veronica Seccia; Apostolos Karligkiotis; Apostolous Karligktios; Ernesto Pasquini; Heinz Stammberger
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-01-12       Impact factor: 2.503

2.  "Fingertip" cryoprobe assisted orbital tumour extraction.

Authors:  P T Finger
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

Review 3.  Endoscopic treatment of orbital tumors.

Authors:  Francesco Signorelli; Carmelo Anile; Mario Rigante; Gaetano Paludetti; Angelo Pompucci; Annunziato Mangiola
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.